How I Choose Between Sculptra and Polynucleotides

One of the questions I am asked most often is whether someone needs Sculptra or polynucleotides. Both are regenerative treatments I use frequently, both stimulate the body rather than simply filling it, and both have become deservedly popular. Yet they do quite different jobs, and choosing well makes all the difference to the result.

Here is how I think it through in my own practice, so you can understand the reasoning before we ever discuss your face specifically.

Sculptra Treatment (Before and immiedetly After) by Dr Vahe

The two treatments

What Sculptra does

Sculptra is a collagen biostimulator made from poly-L-lactic acid. Rather than adding volume directly, it prompts your own body to produce new collagen over the following weeks and months. That makes it a tool for restoring structure and foundation: replacing volume that has been lost across larger areas such as the cheeks and temples, and improving firmness over a region. Its effect builds gradually and can last in the region of two years.

What polynucleotides do

Polynucleotides are regenerative skin treatments derived from purified DNA fragments. They work on the quality of the skin itself, improving hydration, elasticity, thickness and overall health, and calming inflammation. They are my go-to for thin, crepey or tired skin, fine lines and delicate areas, and they give that hard-to-describe improvement in skin quality and freshness. Polynucleotide therapy and polynucleotide-based options such as Rejuran sit firmly in this category.

How I decide

The first question: volume or skin quality?

This is the question that settles most cases. If the main problem is lost volume and a deflated, sagging foundation, I lean towards Sculptra. If the main problem is the quality of the skin itself, thin, dull, crepey or fragile, I lean towards polynucleotides. Naming the true problem is most of the work.

The area being treated

Location matters a great deal. For broad, deeper areas such as the cheeks and temples, where structure and volume are the goal, Sculptra is well suited. For delicate areas such as the under-eyes and neck, or for treating skin quality across the face, polynucleotides are the safer and more appropriate choice.

The condition of the skin

I look closely at the skin itself. Thin, fragile or sun-damaged skin usually needs regeneration before anything else, which points to polynucleotides. Skin that is reasonably robust but sitting on a deflated foundation points towards Sculptra to rebuild that structure.

Your goals and timeline

Both treatments work gradually rather than instantly, so neither suits someone wanting an immediate change for an event next week. I also consider whether the goal is prevention and maintaining healthy skin, where polynucleotides excel, or correcting more advanced volume loss, where Sculptra tends to do more.

When I combine them

Very often the honest answer is not one or the other, but both, in the right order. I frequently use polynucleotides to improve the quality and resilience of the skin, and Sculptra to restore the underlying volume and collagen foundation. Think of it as caring for the soil and rebuilding the structure at the same time: the skin looks healthier and the face looks better supported, and the results complement each other.

Care

What to expect from either

Both treatments are typically given as a short course of sessions rather than a single appointment, with results developing over the following weeks. Downtime is usually minimal, perhaps some swelling, redness or bruising. Because the effects are built rather than instant, a little patience is rewarded with a natural, gradual improvement.

Choosing what is right for you

No article can replace seeing your face in person. The right choice depends on your skin, your anatomy and your goals, and sometimes the best plan only becomes clear in consultation. What I can promise is an honest recommendation, even when that means suggesting less treatment rather than more.

Not sure which is right for you? A consultation at Dr Vahe Clinic will identify whether Sculptra, polynucleotides or a combination best suits your skin and goals. Book a consultation.

A personal note

The most common mistake I see is reaching for volume when the real problem is skin quality, or vice versa. Matching the treatment to the actual cause, rather than to whatever is most talked about, is what produces results that look natural and last.

My aim is always for you to look like a healthier, fresher version of yourself, never overdone. That principle guides every recommendation I make in Chelsea.

Frequently asked questions

Which lasts longer, Sculptra or polynucleotides?

Sculptra's collagen-building effect tends to last longer, often up to around two years, because it rebuilds structural volume. Polynucleotides improve skin quality and are usually maintained with periodic top-ups, as their effect is on the health of the skin rather than on volume.

Can I have Sculptra and polynucleotides together?

Yes, and I often combine them. Polynucleotides improve the quality and resilience of the skin while Sculptra restores the underlying volume and collagen foundation, so used together they address both the surface and the structure.

Which is better for under-eyes?

For the delicate under-eye area, I almost always favour polynucleotides. They improve thin, crepey skin and overall quality, whereas Sculptra is designed for broader volume restoration and is not suited to this fragile region.

Before and after 1 session of Polynucleotides treatment for under eyes area

Which is better for volume loss?

For genuine volume loss and a deflated, sagging foundation, Sculptra is usually the better choice because it stimulates collagen and restores structure over larger areas. Polynucleotides are not volumisers.

References

1. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plastic and Reconstructive Surgery. 2006;118(3 Suppl):46S-54S.

2. Fitzgerald R, Vleggaar D. Using poly-L-lactic acid (PLLA) to mimic volume in multiple tissue layers. Journal of Drugs in Dermatology. 2009;8(10 Suppl):s5-s14.

3. Cavallini M, Bartoletti E, Maioli L, et al. Consensus report on the use of polynucleotides in aesthetic medicine. Journal of Cosmetic Dermatology. 2021;20(3):922-928.

This article reflects general clinical experience and does not replace personalised medical advice. Reviewed by Dr Vahe Karimyan MD, MS, PhD.